SRPT · ISSUER CIK 873303
Sarepta Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Sarepta Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202620:05 | Sep 4, 2026 | SRPT | Chief Financial Officer | F · Tax | $22.22 | −13,272 | 121,792 | -10% | $295K | ||
| Sep 8, 202620:03 | Sep 4, 2026 | SRPT | Chief Operating Officer | F · Tax | $22.22 | −24,799 | 177,184 | -12% | $551K | ||
| Sep 8, 202620:02 | Sep 4, 2026 | SRPT | EVP, General Counsel | F · Tax | $22.22 | −22,025 | 115,519 | -16% | $489K | ||
| Sep 8, 202620:01 | Sep 4, 2026 | SRPT | President, R&D and Tech Ops | F · Tax | $22.22 | −21,423 | 203,900 | -10% | $476K |